Chapin Davis’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
Chapin Davis's AMGN Position: Q2 2026 in Review
Chapin Davis reduced its Amgen (AMGN) stake by 1.7% in Q2 2026, selling an estimated $36.6K and leaving 6,153 shares worth $2.23M. The position accounts for 0.39% of the portfolio, ranked #46.
Chapin Davis first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Chapin Davis held 6,153 shares of Amgen worth $2.23M as of Q2 2026.
- Chapin Davis sold 107 Amgen shares in Q2 2026, an estimated $36.6K.
- Amgen made up 0.39% of Chapin Davis's portfolio in Q2 2026, its #46 holding.
- Chapin Davis first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
- 1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Chapin Davis's 13F filing for Q2 2026, filed 7 Jul 2026.